- Home
- FRSX vs AIDX Comparison
FRSX vs AIDX Comparison
Compare FRSX & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRSX | AIDX |
|---|---|---|
| Founded | N/A | 2000 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 5.6M |
| IPO Year | 2016 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FRSX | AIDX |
|---|---|---|
| Price | $1.08 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 85.6K | 49.5K |
| Earning Date | 10-06-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.48 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,045,133.00 |
| Revenue This Year | $90.14 | $44.20 |
| Revenue Next Year | $154.13 | $95.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.71 |
| 52 Week Low | $0.78 | $0.40 |
| 52 Week High | $3.00 | $14.09 |
Technical Indicators
Market Signals| Indicator | FRSX | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 41.84 |
| Support Level | $1.05 | $0.40 |
| Resistance Level | $1.14 | $0.49 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 14.29 | 23.94 |
Price Performance
Historical ComparisonAbout FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications. The company designs, develops, and commercializes in-line-of-sight vision systems and beyond-line-of-sight accident prevention solutions through its subsidiaries. Its solutions are based on stereo vision, 3D perception, and V2X technologies, aimed at improving safety by enabling accurate obstacle detection and real-time alerts. The company targets multiple industries, including automotive, defense, agriculture, and heavy equipment.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.